{"SPADE_N_15396": {"Sequence Information": {"Peptide Name": "Lantibiotic Duramycin", "Sequence": "CKQSCXFGPFTFVCXGNTK", "Sequence Length": 19, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Antiviral"], "Binding Target": "1. Membrane Protein", "Source": "1. Streptoverticillium griseoverticillatum PA-48009", "Gene": "", "PDB ID": "", "UniProt Entry": [{"uniprotId": "P36504", "uniprotUrl": "http://www.uniprot.org/uniprot/P36504", "description": "The amino acid sequence of the current peptide coincides with the amino acid sequence of the UniProt entry."}], "Literature": [{"Title": "The structure of PA48009: the revised structure of duramycin", "Pubmed ID": "2272918", "Reference": "J Antibiot (Tokyo). 1990;43:1421-1430", "Author": "Hayashi F, Nagashima K, Terui Y, Kawamura Y, Matsumoto K, Itazaki H", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/2272918"}, {"Title": "Labyrinthopeptins Exert Broad-Spectrum Antiviral Activity through Lipid-Binding-Mediated Virolysis.", "Pubmed ID": "31666384", "Reference": "J Virol. 2020;94:e01471-19", "Author": "Prochnow H, Rox K, Birudukota NVS, Weichert L, et al.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/31666384"}], "SPADE ID": "SPADE_N_15396", "Similar Sequences": [{"SPADE_ID": "SPADE_N_00048", "Similarity": 1.0, "Sequence": "CKQSCSFGPFTFVCDGNTK"}, {"SPADE_ID": "SPADE_N_00050", "Similarity": 0.9411764705882353, "Sequence": "CRQSCSFGPFTFVCDGNTK"}, {"SPADE_ID": "SPADE_N_06055", "Similarity": 0.9411764705882353, "Sequence": "MTASILQQSVVDADFRAALLENPAAFGASAAALPTPVEAQDQASLDFWTKDIAATEAFACRQSCSFGPFTFVCDGNTK"}], "Hemolytic Activity": "", "Target Organism": "Bacillus subtilis NRRL B-765(MIC=0.6µg/ml),Bacillus subtilis NRRL B-971(MIC=0.2µg/ml),Bacillus cereus NRRL B-1877(MIC=0.4µg/ml),Enterococcus faecalis NRRL B-537(MIC=>100µg/ml),Escherichia coli NRRL B-766(MIC=>100µg/ml),Pseudomonas aeruginosa NRRL B-23(MIC=>100µg/ml),DENV-2(no activity data)"}}}